Cell News and Research

RSS

Delayed umbilical cord clamping improves survival of extremely premature infants

New research shows delayed umbilical cord clamping improves survival and reduces risk of brain injury in extremely premature infants.

2 Apr 2019

Potential target for Group A Streptococcus vaccine identified

Most people think of "strep throat" as a relatively benign infection cured by a round of antibiotics and a few days of rest. But the bacterium that causes strep throat -- Group A Streptococcus -- is also responsible for a number of much more dangerous disorders, including rheumatic heart disease and toxic shock syndrome.

1 Apr 2019

Study finds cellular protein as a 'gas pump attendant' of cancer development

The cells which make up our body vary significantly. A liver cell does not look like a muscle cell and each has a unique function. This is because liver cells produce the proteins that characterize them, and muscle cells do the same.

1 Apr 2019

Researchers explore biological mechanisms behind obesity-cancer link

New studies led by University of North Carolina Lineberger Comprehensive Cancer Center researchers explore biological mechanisms behind obesity and its link with cancer.

1 Apr 2019

Study reveals investigational drug as effective treatment for relapsed marginal zone lymphoma

A study at The University of Texas MD Anderson Cancer Center revealed the investigational drug umbralisib as an effective treatment for patients with relapsed marginal zone lymphoma.

1 Apr 2019

3D Bioprinting and its Applications

In this interview, AZoM speaks to members of SunP Biotech about 3D bioprinting and its applications.

From SunP Biotech 1 Apr 2019

Household dust may be contributing to childhood obesity epidemic

New research has found that chemicals found in household dust may promote fat cell development and contribute to increased weight gain in children.

1 Apr 2019

Scientists have more evidence of why clear margins in breast cancer surgery are such good news

When a breast cancer tumor is removed with no signs of cancer left behind, it's great news for patients, and now scientists have more evidence of why.

1 Apr 2019

Fish slime could be a potential source of antibiotics finds study

With the advent of multi-drug resistant bacteria and lack of new antibiotics, researchers have been on the lookout for new molecules that can fight these pathogens. A team of researchers have now identified a slimy mucous coating of young fish as a potential source for antibiotics that could fight resistant infections such as MRSA (Methicillin Resistant Staphylococcus aureus).

31 Mar 2019

ETH researchers take major step towards personalized cancer immunotherapy

Cells belonging to the body's own immune system can help fight tumours. For several years now, this has allowed oncologists to use medications known as checkpoint inhibitors to encourage T cells to eliminate tumor cells.

30 Mar 2019

Scientists develop new accurate computational method to enhance drug target stability

Scientists from the Moscow Institute of Physics and Technology, the Skolkovo Institute of Science and Technology, and the University of Southern California have developed a new computational method for the design of thermally stable G protein-coupled receptors that are of great help in creating new drugs.

30 Mar 2019

Research reveals genomic basis of acute erythroid leukemia

Acute erythroid leukemia is a high-risk cancer with a dismal prognosis, uncertain genetic basis and controversy surrounding the diagnosis. That is changing, thanks to research led by St. Jude Children's Research Hospital that appears today in the journal Nature Genetics.

30 Mar 2019

Study provides better understanding of how cilia work and what causes oscillations

Human bodies have some built-in systems to care for themselves. The cells that line our lungs, nose, brain and reproductive system have cilia, which are tiny, hair-like structures designed to sweep out fluids, cells and microbes to stay healthy.

30 Mar 2019

Novel EU-funded project in the field of genomics

The European Advanced infraStructure for Innovative Genomics (EASI-Genomics), a project funded under the European Union's research and innovation programme Horizon 2020, will provide researchers free-of-charge access to cutting-edge European genomics facilities.

30 Mar 2019

New combination therapy found to be well tolerated in patients with aggressive brain tumor

A phase I clinical trial that set out to assess the safety of a new combination therapy for a type of aggressive brain tumour has found the treatment to be well tolerated in patients.

30 Mar 2019

Designer organelles in living mammalian cells can build synthetic proteins

A research team led by biophysical chemist Professor Edward Lemke has engineered a designer organelle in a living mammalian cell in a new complex biological translation process. The created membraneless organelle can build proteins from natural and synthetic amino acids carrying new functionalities.

30 Mar 2019

Cellular mechanism that connects smoking during pregnancy and baby’s obesity risk identified

Using foreskin tissue from newborn circumcisions, a group of researchers have identified a potential cellular mechanism that connects a mother's smoking while pregnant with an increased risk of offspring obesity later in life.

30 Mar 2019

IASLC 2019 Small Cell Lung Cancer Meeting focuses on immunotherapy and patient perspective

While non-small cell lung cancer is the more common form of lung cancer and attracts the lion's share of the research funding, recent developments in small cell lung cancer may be shifting that slightly.

29 Mar 2019

UA immunobiology professor will use $1.9 million grant to study copper's therapeutic potential

Pneumonia starts like this: A bacterial cell called Streptococcus pneumoniae enters the nostril. It travels down the nasal passage and into the lungs, where a war begins. In the lungs, S. pneumoniae encounters immune cells called macrophages, which will do whatever they can to fight it off.

29 Mar 2019

FDA approves new oral drug to treat relapsing forms of multiple sclerosis

The U.S. Food and Drug Administration today approved Mavenclad (cladribine) tablets to treat relapsing forms of multiple sclerosis (MS) in adults, to include relapsing-remitting disease and active secondary progressive disease.

29 Mar 2019

Cell News and Research

Delayed umbilical cord clamping improves survival of extremely premature infants

Potential target for Group A Streptococcus vaccine identified

Study finds cellular protein as a 'gas pump attendant' of cancer development

Researchers explore biological mechanisms behind obesity-cancer link

Study reveals investigational drug as effective treatment for relapsed marginal zone lymphoma

3D Bioprinting and its Applications

Household dust may be contributing to childhood obesity epidemic

Scientists have more evidence of why clear margins in breast cancer surgery are such good news

Fish slime could be a potential source of antibiotics finds study

ETH researchers take major step towards personalized cancer immunotherapy

Scientists develop new accurate computational method to enhance drug target stability

Research reveals genomic basis of acute erythroid leukemia

Study provides better understanding of how cilia work and what causes oscillations

Novel EU-funded project in the field of genomics

New combination therapy found to be well tolerated in patients with aggressive brain tumor

Designer organelles in living mammalian cells can build synthetic proteins

Cellular mechanism that connects smoking during pregnancy and baby’s obesity risk identified

IASLC 2019 Small Cell Lung Cancer Meeting focuses on immunotherapy and patient perspective

UA immunobiology professor will use $1.9 million grant to study copper's therapeutic potential

FDA approves new oral drug to treat relapsing forms of multiple sclerosis

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring